{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:56:34Z","timestamp":1783104994460,"version":"3.54.6"},"reference-count":106,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:sec><jats:title>CONTEXT:<\/jats:title><jats:p>The effectiveness of many interventions aimed at reducing the risk of retinopathy has not been well established.<\/jats:p><\/jats:sec><jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To estimate the effectiveness of nutritional interventions, oxygen saturation targeting, blood transfusion management, and infection prevention on the incidence of retinopathy of prematurity (ROP).<\/jats:p><\/jats:sec><jats:sec><jats:title>DATA SOURCES:<\/jats:title><jats:p>A comprehensive search of several databases was conducted, including Medline, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus through March 2014.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY SELECTION:<\/jats:title><jats:p>We included studies that evaluated nutritional interventions, management of supplemental oxygen, blood transfusions, or infection reduction and reported the incidence of ROP and mortality in neonates born at &amp;lt;32 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>DATA EXTRACTION:<\/jats:title><jats:p>We extracted patient characteristics, interventions, and risk of bias indicators. Outcomes of interest were any stage ROP, severe ROP or ROP requiring treatment, and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>We identified 67 studies enrolling 21\u2009819 infants. Lower oxygen saturation targets reduced the risk of developing any stage ROP (relative risk [RR] 0.86, 95% confidence interval [CI], 0.77\u20130.97) and severe ROP or ROP requiring intervention (RR 0.58, 95% CI, 0.45\u20130.74) but increased mortality (RR 1.15, 95% CI, 1.04\u20131.29). Aggressive parenteral nutrition reduced the risk of any stage ROP but not severe ROP. Supplementation of vitamin A, E, or inositol and breast milk feeding were beneficial but only in observational studies. Use of transfusion guidelines, erythropoietin, and antifungal agents were not beneficial.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS:<\/jats:title><jats:p>Results of observational studies were not replicated in randomized trials. Interventions were heterogeneous across studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>At the present time, there are no safe interventions supported with high quality evidence to prevent severe ROP.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2015-3387","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T13:12:31Z","timestamp":1457529151000},"source":"Crossref","is-referenced-by-count":76,"title":["Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis"],"prefix":"10.1542","volume":"137","author":[{"given":"Jennifer L.","family":"Fang","sequence":"first","affiliation":[{"name":"Divisions of Neonatal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sorita","sequence":"additional","affiliation":[{"name":"Hospital Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Carey","sequence":"additional","affiliation":[{"name":"Divisions of Neonatal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Colby","sequence":"additional","affiliation":[{"name":"Divisions of Neonatal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Preventive Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fares","family":"Alahdab","sequence":"additional","affiliation":[{"name":"Preventive Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"issue":"1","key":"2021120919103131200_B1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity.","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"2021120919103131200_B2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clp.2013.02.008","article-title":"Outcome of retinopathy of prematurity.","volume":"40","author":"Holmstr\u00f6m","year":"2013","journal-title":"Clin Perinatol"},{"issue":"9902","key":"2021120919103131200_B3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity.","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"2021120919103131200_B4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening.","volume":"123","author":"Hellstr\u00f6m","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"2021120919103131200_B5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.","volume":"124","author":"L\u00f6fqvist","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2021120919103131200_B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5694\/j.1326-5377.1951.tb109040.x","article-title":"Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach.","volume":"2","author":"Campbell","year":"1951","journal-title":"Med J Aust"},{"issue":"9","key":"2021120919103131200_B7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations.","volume":"35","author":"Patz","year":"1952","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2021120919103131200_B8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000356561","article-title":"Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies.","volume":"105","author":"Saugstad","year":"2014","journal-title":"Neonatology"},{"issue":"6","key":"2021120919103131200_B9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s004310050641","article-title":"Blood transfusion. Iron load and retinopathy of prematurity.","volume":"156","author":"Hesse","year":"1997","journal-title":"Eur J Pediatr"},{"key":"2021120919103131200_B10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/14767058.2013.830836","article-title":"Instituting a program to reduce the erythrocyte transfusion rate was accompanied by reductions in the incidence of bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis.","volume":"26","author":"Del Vecchio","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4 pt 1","key":"2021120919103131200_B11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1542\/peds.101.4.654","article-title":"Candida sepsis and association with retinopathy of prematurity.","volume":"101","author":"Mittal","year":"1998","journal-title":"Pediatrics"},{"issue":"1","key":"2021120919103131200_B12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.jp.7211420","article-title":"Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates.","volume":"26","author":"Manzoni","year":"2006","journal-title":"J Perinatol"},{"issue":"12","key":"2021120919103131200_B13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archophthalmol.2011.319","article-title":"Neonatal bacteremia and retinopathy of prematurity: the ELGAN study.","volume":"129","author":"Tolsma","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"2021120919103131200_B14","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2021120919103131200_B15","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"2021120919103131200_B16","unstructured":"Wells\u2008GASB, O\u2019Connell\u2008D, Peterson\u2008J, Welch\u2008V, Losos\u2008M, Tugwell\u2008P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed June 1, 2014"},{"issue":"3","key":"2021120919103131200_B17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"2021120919103131200_B18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"2021120919103131200_B19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"5","key":"2021120919103131200_B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end.","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw"},{"issue":"1","key":"2021120919103131200_B21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archpedi.157.1.66","article-title":"The effect of maternal milk on neonatal morbidity of very low-birth-weight infants.","volume":"157","author":"Furman","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"2021120919103131200_B22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.jp.7210548","article-title":"Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants.","volume":"21","author":"Hylander","year":"2001","journal-title":"J Perinatol"},{"issue":"4","key":"2021120919103131200_B23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jpeds.2009.10.040","article-title":"An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products.","volume":"156","author":"Sullivan","year":"2010","journal-title":"J Pediatr"},{"key":"2021120919103131200_B24","first-page":"1592","article-title":"Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants","volume-title":"J Pediatr","author":"Cristofalo","year":"2013"},{"issue":"2","key":"2021120919103131200_B25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0031-1295652","article-title":"Human milk versus formula feeding among preterm infants: short-term outcomes.","volume":"29","author":"Maayan-Metzger","year":"2012","journal-title":"Am J Perinatol"},{"issue":"4","key":"2021120919103131200_B26","first-page":"403","article-title":"Early aggressive parenteral nutrition induced high insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) levels can prevent risk of retinopathy of prematurity.","volume":"23","author":"Can","year":"2013","journal-title":"Iran J Pediatr"},{"issue":"3","key":"2021120919103131200_B27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jpeds.2013.03.059","article-title":"Safety and efficacy of early parenteral lipid and high-dose amino acid","volume":"163","author":"Vlaardingerbroek","year":"2013","journal-title":"J Pediatr"},{"issue":"5","key":"2021120919103131200_B28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0884533611418984","article-title":"Implementation, process, and outcomes of nutrition best practices for infants &lt;1500 g.","volume":"26","author":"Hanson","year":"2011","journal-title":"Nutr Clin Pract"},{"issue":"4","key":"2021120919103131200_B29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1542\/peds.2007-2282","article-title":"Randomized trial of very low birth weight infants receiving higher rates of infusion of intravenous fat emulsions during the first week of life.","volume":"122","author":"Drenckpohl","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"2021120919103131200_B30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.earlhumdev.2013.11.002","article-title":"The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial.","volume":"90","author":"Beken","year":"2014","journal-title":"Early Hum Dev"},{"issue":"2","key":"2021120919103131200_B31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.2010-2427","article-title":"Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants.","volume":"127","author":"Pawlik","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"2021120919103131200_B32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jpeds.2011.12.013","article-title":"Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity","volume":"160","author":"Mactier","year":"2012","journal-title":"J Pediatr"},{"issue":"1","key":"2021120919103131200_B33","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1136\/fn.84.1.F9","article-title":"Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease.","volume":"84","author":"Wardle","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2021120919103131200_B34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3476(87)80086-0","article-title":"Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.","volume":"111","author":"Shenai","year":"1987","journal-title":"J Pediatr"},{"issue":"5","key":"2021120919103131200_B35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pedneo.2013.12.002","article-title":"Effectiveness of vitamin a in the prevention of complications of prematurity.","volume":"55","author":"Uberos","year":"2014","journal-title":"Pediatr Neonatol"},{"issue":"5","key":"2021120919103131200_B36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3476(89)80149-0","article-title":"Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.","volume":"114","author":"Johnson","year":"1989","journal-title":"J Pediatr"},{"issue":"4","key":"2021120919103131200_B37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1542\/peds.79.4.489","article-title":"Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial.","volume":"79","author":"Phelps","year":"1987","journal-title":"Pediatrics"},{"issue":"6","key":"2021120919103131200_B38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1542\/peds.74.6.1107","article-title":"Intraventricular hemorrhage and vitamin E in the very low-birth-weight infant: evidence for efficacy of early intramuscular vitamin E administration.","volume":"74","author":"Speer","year":"1984","journal-title":"Pediatrics"},{"issue":"5","key":"2021120919103131200_B39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0161-6420(83)34535-8","article-title":"Vitamin E and retrolental fibroplasia. Improved visual outcome with early vitamin E.","volume":"90","author":"Finer","year":"1983","journal-title":"Ophthalmology"},{"issue":"3","key":"2021120919103131200_B40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1542\/peds.71.3.423","article-title":"Retrolental fibroplasia: further clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant.","volume":"71","author":"Hittner","year":"1983","journal-title":"Pediatrics"},{"issue":"8281","key":"2021120919103131200_B41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(82)92276-0","article-title":"Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial.","volume":"1","author":"Finer","year":"1982","journal-title":"Lancet"},{"issue":"2","key":"2021120919103131200_B42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0161-6420(82)34830-7","article-title":"Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome.","volume":"89","author":"Puklin","year":"1982","journal-title":"Ophthalmology"},{"issue":"23","key":"2021120919103131200_B43","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM198112033052301","article-title":"Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants.","volume":"305","author":"Hittner","year":"1981","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120919103131200_B44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3928\/0191-3913-20000301-06","article-title":"Relationship between serum inositol concentration and development of retinopathy of prematurity: a prospective study.","volume":"37","author":"Friedman","year":"2000","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"19","key":"2021120919103131200_B45","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJM199205073261901","article-title":"Inositol supplementation in premature infants with respiratory distress syndrome.","volume":"326","author":"Hallman","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120919103131200_B46","first-page":"25","article-title":"Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial.","volume":"30","author":"Manzoni","year":"2013","journal-title":"Am J Perinatol"},{"key":"2021120919103131200_B47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14767058.2011.607618","article-title":"A prospective, randomized, double blind study comparing lutein to placebo for reducing occurrence and severity of retinopathy of prematurity.","volume":"24","author":"Romagnoli","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"20","key":"2021120919103131200_B48","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2013.5555","article-title":"Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial.","volume":"309","author":"Schmidt","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"2021120919103131200_B49","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bjophthalmol-2011-301394","article-title":"Impact of changing oxygenation policies on retinopathy of prematurity in a neonatal unit in Argentina.","volume":"96","author":"Urrets-Zavalia","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2021120919103131200_B50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaapos.2011.10.008","article-title":"Effect of the oxygen saturation target on clinical characteristics of early- versus late-onset retinopathy of prematurity.","volume":"16","author":"Tlucek","year":"2012","journal-title":"J AAPOS"},{"issue":"2","key":"2021120919103131200_B51","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1651-2227.2010.02001.x","article-title":"Prevention of retinopathy of prematurity in preterm infants through changes in clinical practice and SpO\u2082technology.","volume":"100","author":"Castillo","year":"2011","journal-title":"Acta Paediatr"},{"issue":"5","key":"2021120919103131200_B52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaapos.2010.06.013","article-title":"Effect of decreasing target oxygen saturation on retinopathy of prematurity.","volume":"14","author":"Tlucek","year":"2010","journal-title":"J AAPOS"},{"issue":"21","key":"2021120919103131200_B53","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa0911781","article-title":"Target ranges of oxygen saturation in extremely preterm infants.","volume":"362","author":"Carlo","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"2021120919103131200_B54","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1442-200X.2009.02856.x","article-title":"Reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity in infants of &lt;33 weeks gestation.","volume":"51","author":"Tokuhiro","year":"2009","journal-title":"Pediatr Int"},{"issue":"8","key":"2021120919103131200_B55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/jp.2009.60","article-title":"Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.","volume":"29","author":"Noori","year":"2009","journal-title":"J Perinatol."},{"issue":"3","key":"2021120919103131200_B56","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ophtha.2008.09.051","article-title":"A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity.","volume":"116","author":"Sears","year":"2009","journal-title":"Ophthalmology"},{"issue":"7","key":"2021120919103131200_B57","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1651-2227.2007.00365.x","article-title":"Treatment-by-gender effect when aiming to avoid hyperoxia in preterm infants in the NICU.","volume":"96","author":"Deulofeut","year":"2007","journal-title":"Acta Paediatr"},{"issue":"2","key":"2021120919103131200_B58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaapos.2006.08.012","article-title":"Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels.","volume":"11","author":"Wallace","year":"2007","journal-title":"J AAPOS"},{"key":"2021120919103131200_B59","first-page":"78","article-title":"A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.","volume":"104","author":"Wright","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"5","key":"2021120919103131200_B60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaapos.2006.04.010","article-title":"Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity.","volume":"10","author":"Vanderveen","year":"2006","journal-title":"J AAPOS"},{"issue":"11","key":"2021120919103131200_B61","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.jp.7211608","article-title":"Avoiding hyperoxia in infants &lt; or = 1250 g is associated with improved short- and long-term outcomes.","volume":"26","author":"Deulofeut","year":"2006","journal-title":"J Perinatol"},{"issue":"2","key":"2021120919103131200_B62","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1136\/fn.84.2.F106","article-title":"Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation.","volume":"84","author":"Tin","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"2021120919103131200_B63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jpeds.2012.05.046","article-title":"Low oxygen saturation target range is associated with increased incidence of intermittent hypoxemia.","volume":"161","author":"Di Fiore","year":"2012","journal-title":"J Pediatr"},{"issue":"22","key":"2021120919103131200_B64","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1056\/NEJMoa1302298","article-title":"Oxygen saturation and outcomes in preterm infants.","volume":"368","author":"Stenson","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120919103131200_B65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1875-9572(09)60045-0","article-title":"Effect of blood transfusions on the outcome of very low body weight preterm infants under two different transfusion criteria.","volume":"50","author":"Chen","year":"2009","journal-title":"Pediatr Neonatol"},{"issue":"6","key":"2021120919103131200_B66","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1542\/peds.2004-1884","article-title":"Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants.","volume":"115","author":"Bell","year":"2005","journal-title":"Pediatrics"},{"issue":"3 pt 1","key":"2021120919103131200_B67","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1542\/peds.104.3.514","article-title":"The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study.","volume":"104","author":"Brooks","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"2021120919103131200_B68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpeds.2006.05.011","article-title":"The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.","volume":"149","author":"Kirpalani","year":"2006","journal-title":"J Pediatr"},{"issue":"1","key":"2021120919103131200_B69","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-0143","article-title":"A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants.","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"issue":"11","key":"2021120919103131200_B70","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1592\/phco.28.11.1335","article-title":"Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants.","volume":"28","author":"Schneider","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2021120919103131200_B71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.","volume":"122","author":"Fauch\u00e8re","year":"2008","journal-title":"Pediatrics"},{"issue":"8","key":"2021120919103131200_B72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-2005-918888","article-title":"The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants.","volume":"22","author":"T\u00fcrker","year":"2005","journal-title":"Am J Perinatol"},{"issue":"8","key":"2021120919103131200_B73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","article-title":"Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?","volume":"159","author":"Romagnoli","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"1","key":"2021120919103131200_B74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(96)70194-4","article-title":"Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions.","volume":"129","author":"Al-Kharfy","year":"1996","journal-title":"J Pediatr"},{"issue":"1","key":"2021120919103131200_B75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1442-200x.2005.02007.x","article-title":"Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.","volume":"47","author":"Arif","year":"2005","journal-title":"Pediatr Int"},{"issue":"1","key":"2021120919103131200_B76","doi-asserted-by":"crossref","first-page":"F44","DOI":"10.1136\/fn.79.1.F44","article-title":"Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.","volume":"79","author":"Carnielli","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"2021120919103131200_B77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mpd.2002.124309","article-title":"Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g.","volume":"141","author":"Maier","year":"2002","journal-title":"J Pediatr"},{"issue":"17","key":"2021120919103131200_B78","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","article-title":"The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants.","volume":"330","author":"Maier","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120919103131200_B79","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1542\/peds.108.4.934","article-title":"Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.","volume":"108","author":"Ohls","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"2021120919103131200_B80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.","volume":"95","author":"Shannon","year":"1995","journal-title":"Pediatrics"},{"issue":"4","key":"2021120919103131200_B81","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1440-1754.2001.00667.x","article-title":"Effect of recombinant human erythropoietin on transfusion needs in preterm infants.","volume":"37","author":"Yeo","year":"2001","journal-title":"J Paediatr Child Health"},{"issue":"17","key":"2021120919103131200_B82","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1001\/jama.2014.2624","article-title":"Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.","volume":"311","author":"Benjamin","year":"2014","journal-title":"JAMA"},{"issue":"23","key":"2021120919103131200_B83","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants.","volume":"345","author":"Kaufman","year":"2001","journal-title":"N Engl J Med"},{"issue":"24","key":"2021120919103131200_B84","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa065733","article-title":"A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.","volume":"356","author":"Manzoni","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120919103131200_B85","doi-asserted-by":"crossref","first-page":"F164","DOI":"10.1136\/adc.2009.178996","article-title":"Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants.","volume":"96","author":"Aydemir","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"12","key":"2021120919103131200_B86","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1055\/s-0034-1371358","article-title":"Efficacy of prophylactic fluconazole therapy in decreasing the incidence of Candida infections in extremely low birth weight preterm infants.","volume":"31","author":"Cetinkaya","year":"2014","journal-title":"Am J Perinatol"},{"issue":"6","key":"2021120919103131200_B87","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/pch\/18.6.298","article-title":"Does reducing light exposure decrease the incidence of retinopathy of prematurity in premature infants?","volume":"18","author":"Johannes","year":"2013","journal-title":"Paediatr Child Health"},{"key":"2021120919103131200_B88","first-page":"CD001073","article-title":"D-Penicillamine for preventing retinopathy of prematurity in preterm infants.","volume":"9","author":"Qureshi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2021120919103131200_B89","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3476(97)70031-3","article-title":"Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials.","volume":"131","author":"Raju","year":"1997","journal-title":"J Pediatr"},{"issue":"6","key":"2021120919103131200_B90","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3109\/14767058.2011.589873","article-title":"Effect of low versus high early parenteral nutrition on plasma amino acid profiles in very low birth-weight infants.","volume":"25","author":"Bulbul","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"2021120919103131200_B91","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.jp.7211611","article-title":"Safety and efficacy of early amino acids in preterm &lt;28 weeks gestation: prospective observational comparison.","volume":"26","author":"Kotsopoulos","year":"2006","journal-title":"J Perinatol"},{"issue":"1","key":"2021120919103131200_B92","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1203\/00006450-200301000-00008","article-title":"Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period.","volume":"53","author":"Thureen","year":"2003","journal-title":"Pediatr Res"},{"issue":"4","key":"2021120919103131200_B93","first-page":"CD003665","article-title":"Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.","author":"Brion","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2021120919103131200_B94","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3945\/jn.109.109108","article-title":"Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes.","volume":"139","author":"Brown","year":"2009","journal-title":"J Nutr"},{"issue":"2","key":"2021120919103131200_B95","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.mpg.0000189341.38634.77","article-title":"Free sugar and sugar alcohol concentrations in human breast milk.","volume":"42","author":"Cavalli","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021120919103131200_B96","unstructured":"Enfamil Premature. Mead Johnson Nutrition. Available at: www.enfamil.com\/products\/special-dietary-needs\/enfamil-premature. Accessed July, 23, 2015"},{"key":"2021120919103131200_B97","unstructured":"Similac Special Care 24 with Iron. Abbott Laboratories. Available at: http:\/\/abbottnutrition.com\/brands\/products\/similac-special-care-24-with-iron. Accessed July, 23, 2015"},{"key":"2021120919103131200_B98","unstructured":"Gerber Good Start Premature 24. Soci\u00e9t\u00e9 des Produits Nestl\u00e9. Available at: http:\/\/medical.gerber.com\/products\/formulas\/good-start-premature-24. Accessed July, 23, 2015"},{"key":"2021120919103131200_B99","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development . Inositol to Reduce Retinopathy of Prematurity (INS-3). Available at: https:\/\/clinicaltrials.gov\/show\/NCT01954082NLM identifier: NCT01954082. Accessed July 23, 2015"},{"issue":"11","key":"2021120919103131200_B100","first-page":"CD000512","article-title":"Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants.","author":"Whyte","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120919103131200_B101","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants.","volume":"4","author":"Ohlsson","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120919103131200_B102","first-page":"CD004868","article-title":"Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants.","volume":"4","author":"Aher","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2021120919103131200_B103","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2007.04.060","article-title":"Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.","volume":"151","author":"DeJonge","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"2021120919103131200_B104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.earlhumdev.2012.07.003","article-title":"Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system.","volume":"89","author":"Bertini","year":"2013","journal-title":"Early Hum Dev"},{"issue":"1","key":"2021120919103131200_B105","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-0566","article-title":"Sustained reduction in neonatal nosocomial infections through quality improvement efforts.","volume":"129","author":"Payne","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"2021120919103131200_B106","first-page":"1","article-title":"Births: Final data for 2013.","volume":"64","author":"Martin","year":"2015","journal-title":"Natl Vital Stat Rep"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-3387\/1093679\/peds_20153387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-3387\/1093679\/peds_20153387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T19:59:11Z","timestamp":1655236751000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/137\/4\/e20153387\/81383\/Interventions-To-Prevent-Retinopathy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":106,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,1]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-3387","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]},"article-number":"e20153387"}}